JPY 2704.0
(0.56%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 7.8 Billion JPY | -19.07% |
2022 | 9.63 Billion JPY | 0.19% |
2021 | 9.59 Billion JPY | 21.69% |
2020 | 7.49 Billion JPY | -4.29% |
2019 | 8.24 Billion JPY | 12.6% |
2018 | 7.49 Billion JPY | 14.59% |
2017 | 6.49 Billion JPY | -1.49% |
2016 | 6.19 Billion JPY | 13.32% |
2015 | 5.45 Billion JPY | 5.41% |
2014 | 5.2 Billion JPY | 4.68% |
2013 | 4.93 Billion JPY | 2.1% |
2012 | 4.93 Billion JPY | 15.54% |
2011 | 4.8 Billion JPY | -6.39% |
2010 | 4.58 Billion JPY | 11.49% |
2009 | 4.1 Billion JPY | -6.96% |
2008 | 4.44 Billion JPY | 6.64% |
2007 | 3.51 Billion JPY | -3.62% |
2006 | 4.55 Billion JPY | 2.59% |
2005 | 4.36 Billion JPY | 17.14% |
2004 | 3.69 Billion JPY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 1.89 Billion JPY | -25.27% |
2024 Q2 | 2.4 Billion JPY | -3.37% |
2023 Q2 | 1.92 Billion JPY | 60.7% |
2023 Q3 | 325.66 Million JPY | -83.07% |
2023 Q4 | 2.7 Billion JPY | 729.28% |
2023 FY | - JPY | -19.07% |
2023 Q1 | 1.19 Billion JPY | -36.88% |
2022 Q1 | 1.49 Billion JPY | -28.83% |
2022 FY | - JPY | 0.19% |
2022 Q2 | 2.3 Billion JPY | 54.24% |
2022 Q3 | 1.85 Billion JPY | -19.6% |
2022 Q4 | 1.89 Billion JPY | 2.15% |
2021 Q3 | 2.1 Billion JPY | 5.19% |
2021 Q4 | 2.1 Billion JPY | -0.09% |
2021 Q1 | 1.63 Billion JPY | -21.74% |
2021 Q2 | 2 Billion JPY | 22.45% |
2021 FY | - JPY | 21.69% |
2020 Q2 | 1.35 Billion JPY | 29.15% |
2020 Q1 | 1.04 Billion JPY | -33.67% |
2020 FY | - JPY | -4.29% |
2020 Q4 | 2.08 Billion JPY | 15.21% |
2020 Q3 | 1.81 Billion JPY | 34.21% |
2019 Q1 | 1.26 Billion JPY | -19.99% |
2019 Q4 | 1.57 Billion JPY | -24.68% |
2019 Q2 | 1.83 Billion JPY | 44.93% |
2019 FY | - JPY | 12.6% |
2019 Q3 | 2.09 Billion JPY | 14.21% |
2018 Q4 | 1.58 Billion JPY | -7.45% |
2018 FY | - JPY | 14.59% |
2018 Q2 | 1.58 Billion JPY | 45.97% |
2018 Q1 | 1.08 Billion JPY | -45.88% |
2018 Q3 | 1.7 Billion JPY | 7.86% |
2017 Q1 | 794.33 Million JPY | -49.3% |
2017 FY | - JPY | -1.49% |
2017 Q4 | 2 Billion JPY | 159.1% |
2017 Q3 | 773.29 Million JPY | -50.16% |
2017 Q2 | 1.55 Billion JPY | 95.33% |
2016 FY | - JPY | 13.32% |
2016 Q4 | 1.56 Billion JPY | 10.08% |
2016 Q3 | 1.42 Billion JPY | -5.28% |
2016 Q2 | 1.5 Billion JPY | 62.88% |
2016 Q1 | 922.53 Million JPY | -1.95% |
2015 FY | - JPY | 5.41% |
2015 Q1 | 953.95 Million JPY | -22.97% |
2015 Q2 | 1.38 Billion JPY | 44.98% |
2015 Q3 | 1.41 Billion JPY | 2.49% |
2015 Q4 | 940.89 Million JPY | -33.62% |
2014 FY | - JPY | 4.68% |
2014 Q4 | 1.23 Billion JPY | 20.22% |
2014 Q3 | 1.03 Billion JPY | -14.58% |
2014 Q2 | 1.2 Billion JPY | 26.1% |
2014 Q1 | 956.39 Million JPY | -2.56% |
2013 Q4 | 981.48 Million JPY | -13.53% |
2013 Q1 | 902.83 Million JPY | -9.95% |
2013 FY | - JPY | 2.1% |
2013 Q3 | 1.13 Billion JPY | -12.21% |
2013 Q2 | 1.29 Billion JPY | 43.21% |
2012 Q2 | 1.14 Billion JPY | 36.22% |
2012 Q3 | 1.15 Billion JPY | 1.23% |
2012 Q4 | 1 Billion JPY | -13.24% |
2012 Q1 | 838 Million JPY | 3.5% |
2012 FY | - JPY | 15.54% |
2011 Q1 | 1.1 Billion JPY | -8.95% |
2011 Q2 | 1.22 Billion JPY | 10.29% |
2011 Q3 | 1.26 Billion JPY | 3.7% |
2011 Q4 | 809.68 Million JPY | -36.08% |
2011 FY | - JPY | -6.39% |
2010 Q4 | 1.21 Billion JPY | -6.26% |
2010 Q3 | 1.29 Billion JPY | 2.98% |
2010 FY | - JPY | 11.49% |
2010 Q1 | 932.47 Million JPY | -22.98% |
2010 Q2 | 1.25 Billion JPY | 35.11% |
2009 FY | - JPY | -6.96% |
2009 Q3 | 857.67 Million JPY | -31.74% |
2009 Q1 | 896.51 Million JPY | 0.0% |
2009 Q4 | 1.21 Billion JPY | 41.15% |
2009 Q2 | 1.25 Billion JPY | 40.14% |
2008 FY | - JPY | 6.64% |
2007 FY | - JPY | -3.62% |
2006 FY | - JPY | 2.59% |
2005 FY | - JPY | 17.14% |
2004 FY | - JPY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Kitanotatsujin Corporation | 1.58 Billion JPY | -391.239% |
Euglena Co., Ltd. | 676 Million JPY | -1053.908% |
BEAUTY GARAGE Inc. | 1.96 Billion JPY | -297.002% |
Axas Holdings Co.,Ltd. | 555.75 Million JPY | -1303.564% |
C.I. Medical Co.,Ltd. | 4.01 Billion JPY | -94.379% |
Kao Corporation | 154.49 Billion JPY | 94.951% |
Niitaka Co., Ltd. | 1.36 Billion JPY | -469.572% |
Rohto Pharmaceutical Co.,Ltd. | 48.85 Billion JPY | 84.033% |
Shiseido Company, Limited | 106.46 Billion JPY | 92.673% |
Lion Corporation | 42.31 Billion JPY | 81.565% |
Mandom Corporation | 6.69 Billion JPY | -16.442% |
Ivy Cosmetics Corporation | 242.6 Million JPY | -3115.342% |
Nippon Shikizai, Inc. | 1.28 Billion JPY | -505.352% |
Fancl Corporation | 16.6 Billion JPY | 53.018% |
KOSÉ Corporation | 26.85 Billion JPY | 70.956% |
Cota Co., Ltd. | 2.26 Billion JPY | -243.863% |
HABA Laboratories,Inc. | -1.31 Billion JPY | 693.499% |
C'bon Cosmetics Co.,Ltd. | 171.84 Million JPY | -4439.166% |
Pola Orbis Holdings Inc. | 23.17 Billion JPY | 66.344% |
Noevir Holdings Co., Ltd. | 12.24 Billion JPY | 36.292% |
Adjuvant Holdings Co.,Ltd. | 124 Million JPY | -6190.661% |
Almado, Inc. | 983.21 Million JPY | -693.356% |
I-ne CO., LTD. | 4.7 Billion JPY | -65.966% |
Premier Anti-Aging Co., Ltd. | -627 Million JPY | 1344.086% |
Liberta Co.,Ltd. | 318.19 Million JPY | -2351.482% |
AXXZIA Inc. | 1.28 Billion JPY | -506.325% |
S.T. Corporation | 2.62 Billion JPY | -197.046% |
Kobayashi Pharmaceutical Co., Ltd. | 31.68 Billion JPY | 75.381% |
Earth Corporation | 10.6 Billion JPY | 26.467% |
Sagami Rubber Industries Co., Ltd. | 1.09 Billion JPY | -612.663% |
Asahi Eito Holdings Co.,Ltd. | -573.98 Million JPY | 1459.003% |
Ya-Man Ltd. | 1.43 Billion JPY | -442.913% |
MTG Co., Ltd. | 4.39 Billion JPY | -77.524% |
TRANSACTION CO.,Ltd. | 5.8 Billion JPY | -34.276% |
SHOBIDO Corporation | 1.11 Billion JPY | -602.616% |
Artnature Inc. | 3.78 Billion JPY | -105.979% |
Pigeon Corporation | 15.8 Billion JPY | 50.649% |
Unicharm Corporation | 178.01 Billion JPY | 95.618% |
Paltac Corporation | 35.92 Billion JPY | 78.286% |
CB GROUP MANAGEMENT Co., Ltd. | 3.28 Billion JPY | -137.456% |